Search Results

There are 5719 results for: content related to: Response to Teschke et al.

  1. USP suspected herbal hepatotoxicity: Quality of causality assessment is more important than quantity of counted cases, not vice versa

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 336–338, Rolf Teschke, Wolfgang Schmidt-Taenzer and Albrecht Wolff

    Article first published online : 8 MAR 2012, DOI: 10.1002/pds.3209

  2. Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 12, December 2012, Pages: 1350–1358, Priscilla Velentgas, Anthony A. Amato, Rhonda L. Bohn, K. Arnold Chan, Thomas Cochrane, Donnie P. Funch, Inna Dashevsky, April L. Duddy, Patricia Gladowski, Steven A. Greenberg, Judith M. Kramer, Cheryl McMahill-Walraven, Cynthia Nakasato, Claire M. Spettell, Beth L. Syat, Peter M. Wahl, Alexander M. Walker, Fang Zhang, Jeffrey S. Brown and Richard Platt

    Article first published online : 16 JUL 2012, DOI: 10.1002/pds.3321

  3. Drug-induced Stevens–Johnson syndrome: case series from tertiary care centre in Gujarat

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 384–395, Damodar Bang, Tapan Shah, Divyesh Thakker, Yogesh Shah and Amit D. Raval

    Article first published online : 28 FEB 2012, DOI: 10.1002/pds.3212

  4. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Article first published online : 23 FEB 2012, DOI: 10.1002/pds.3219

  5. You have free access to this content
    Erratum

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 7, July 2012, Page: 787,

    Article first published online : 4 JUL 2012, DOI: 10.1002/pds.3294

    This article corrects:

    Response to Teschke et al.

    Vol. 21, Issue 3, 339–340, Article first published online: 8 MAR 2012

    This article corrects:
  6. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 567–582, Rolf Teschke, Wolfgang Schmidt-Taenzer and Albrecht Wolff

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2127

  7. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1202–1215, Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

    Article first published online : 4 JUL 2012, DOI: 10.1002/pds.3318

  8. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  9. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 343–351, Agnès Fournier and Mahmoud Zureik

    Article first published online : 9 FEB 2012, DOI: 10.1002/pds.3213

  10. The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 691–699, B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, AB Almarsdottir, M Andersen, K Andersson Sundell, U Bergman, A Helin-Salmivaara, M Hoffmann, H Kieler, JE Martikainen, M Mortensen, M Petzold, H Wallach-Kildemoes, C Wallin and HT Sørensen

    Article first published online : 23 MAY 2013, DOI: 10.1002/pds.3457

  11. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 494–506, Christopher G. Rowan, Steven M. Brunelli, Jeffrey Munson, James Flory, Peter P. Reese, Sean Hennessy, James Lewis, Daniel Mines, Jeffrey S. Barrett, Warren Bilker and Brian L. Strom

    Article first published online : 16 MAR 2012, DOI: 10.1002/pds.3199

  12. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Article first published online : 6 JUN 2012, DOI: 10.1002/pds.3291

  13. Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 783–793, Jennifer N. Lind, Sarah C. Tinker, Cheryl S. Broussard, Jennita Reefhuis, Suzan L. Carmichael, Margaret A. Honein, Richard S. Olney, Samantha E. Parker, Martha M. Werler and for the National Birth Defects Prevention Study

    Article first published online : 26 APR 2013, DOI: 10.1002/pds.3448

  14. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1155–1172, Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

    Article first published online : 9 AUG 2012, DOI: 10.1002/pds.3329

  15. Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 5, May 2013, Pages: 447–458, Suzanne L. West, Linda B. Squiers, Lauren McCormack, Brian G. Southwell, Emily S. Brouwer, Mahima Ashok, Linda Lux, Vanessa Boudewyns, Amie O'Donoghue and Helen W. Sullivan

    Article first published online : 26 FEB 2013, DOI: 10.1002/pds.3416

  16. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  17. The impact of diabetes mellitus and its control on the development of tuberculosis: a nationwide longitudinal study in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 995–1003, Ming-Chia Lee, Chih-Hsin Lee, Chin-Chung Shu, Wei-Bang Pong, Chou-Chin Lan, Jann-Yuan Wang, Li-Na Lee and Kun-Mao Chao

    Article first published online : 30 JUL 2013, DOI: 10.1002/pds.3491

  18. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 335–344, Sharon K. Greene, Lingling Li, David K. Shay, Alicia M. Fry, Grace M. Lee, Steven J. Jacobsen, Roger Baxter, Stephanie A. Irving, Michael L. Jackson, Allison L. Naleway, James D. Nordin, Komal J. Narwaney and Tracy A. Lieu

    Article first published online : 5 NOV 2012, DOI: 10.1002/pds.3363

  19. Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 40–54, Sarah L. Cutrona, Sengwee Toh, Aarthi Iyer, Sarah Foy, Gregory W. Daniel, Vinit P. Nair, Daniel Ng, Melissa G. Butler, Denise Boudreau, Susan Forrow, Robert Goldberg, Joel Gore, David McManus, Judith A. Racoosin and Jerry H. Gurwitz

    Article first published online : 29 JUN 2012, DOI: 10.1002/pds.3310

  20. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Article first published online : 21 NOV 2012, DOI: 10.1002/pds.3377